Ron MD - BioLight Life Chief Board
BOLT Stock | ILS 671.00 9.00 1.32% |
Insider
Ron MD is Chief Board of BioLight Life Sciences
Age | 68 |
Phone | 972 7 327 53400 |
Web | https://bio-light.co.il |
BioLight Life Management Efficiency
The company has return on total asset (ROA) of (0.0925) % which means that it has lost $0.0925 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.0911) %, meaning that it generated substantial loss on money invested by shareholders. BioLight Life's management efficiency ratios could be used to measure how well BioLight Life manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | INSIDER Age | ||
Levi Shtresler | Azorim Investment Development | 52 | |
Elad Aharonson | ICL Israel Chemicals | 49 | |
Daniel Shapira | Oron Group Investments | 69 | |
Roi Padida | Suny Cellular Communication | 37 | |
Yoni Barel | Azorim Investment Development | 32 | |
Tomer Raved | B Communications | 38 | |
Lital Aharoni | B Communications | N/A | |
Yaniv Salomon | B Communications | N/A | |
Zvi Rotenberg | Oron Group Investments | N/A | |
Anantha Desikan | ICL Israel Chemicals | 51 | |
Ern Levy | Suny Cellular Communication | 48 | |
Eli Amon | ICL Israel Chemicals | 54 | |
Efrat Ozen | Oron Group Investments | 45 | |
Giora Bitan | Suny Cellular Communication | 68 | |
Amir Meshulam | ICL Israel Chemicals | 43 | |
Ziv Leitman | Suny Cellular Communication | 64 | |
Aviram Lahav | ICL Israel Chemicals | 64 | |
Ilan Chaikin | B Communications | 69 | |
Inbal Korland | Oron Group Investments | N/A | |
Sigal Halevy | Azorim Investment Development | N/A | |
Lilach Erez | Azorim Investment Development | N/A |
Management Performance
Return On Equity | -0.0911 | |||
Return On Asset | -0.0925 |
BioLight Life Sciences Leadership Team
Elected by the shareholders, the BioLight Life's board of directors comprises two types of representatives: BioLight Life inside directors who are chosen from within the company, and outside directors, selected externally and held independent of BioLight. The board's role is to monitor BioLight Life's management team and ensure that shareholders' interests are well served. BioLight Life's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, BioLight Life's outside directors are responsible for providing unbiased perspectives on the board's policies.
Yifftach CPA, Chief Officer | ||
Ronit Gross, CoFounder | ||
Karin Gurevitz, Vice President General Counsel, Secretary | ||
Ron MD, Chief Board | ||
Yaacov Michlin, Chief Officer |
BioLight Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is BioLight Life a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -0.0911 | |||
Return On Asset | -0.0925 | |||
Current Valuation | 13.59 M | |||
Shares Outstanding | 4.56 M | |||
Shares Owned By Insiders | 56.36 % | |||
Shares Owned By Institutions | 9.12 % | |||
Price To Earning | 82.18 X | |||
Price To Book | 0.61 X | |||
Price To Sales | 4,937 X | |||
Revenue | 3 K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in BioLight Stock
BioLight Life financial ratios help investors to determine whether BioLight Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BioLight with respect to the benefits of owning BioLight Life security.